{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:39Z","timestamp":1791923079918,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.gore.2025.101684","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:24:44Z","timestamp":1737995084000},"page":"101684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recurrence and survival in high-intermediate risk endometrial cancers with isolated tumor cell lymph node metastasis"],"prefix":"10.1016","volume":"57","author":[{"given":"Ahmad","family":"Awada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando O.","family":"Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie D.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2025.101684_b0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2021.02.017","article-title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: to treat or not to treat?","volume":"161","author":"Backes","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101684_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ijgc-2023-005032","article-title":"Prognostic value of isolated tumor cells in sentinel lymph nodes in low-risk endometrial cancer: results from an international multi-institutional study","volume":"34","author":"Cucinella","year":"2024","journal-title":"Int. J. Gynecol. Cancer."},{"key":"10.1016\/j.gore.2025.101684_b0015","first-page":"206","article-title":"Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis","volume":"141","author":"Holloway","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101684_b0020","doi-asserted-by":"crossref","unstructured":"Keys, H.M., Roberts, J.A., Brunetto, V.L., 2004. et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study [published correction appears in Gynecol. Oncol. 2004; 94 (1): 241-2]. Gynecol. Oncol. 92, 744-751.","DOI":"10.1016\/j.ygyno.2003.11.048"},{"key":"10.1016\/j.gore.2025.101684_b0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2022.02.015","article-title":"Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer","volume":"165","author":"Matsuo","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2025.101684_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0988","article-title":"Lymph node isolated tumor cells in patients with endometrial cancer","volume":"7","author":"Matsuo","year":"2024","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.gore.2025.101684_b0035","unstructured":"NCCN Guidelines Version 2.2024. Uterine Neoplasms https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1473. Accessed October 2, 2024."},{"key":"10.1016\/j.gore.2025.101684_b0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2017.05.024","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?","volume":"146","author":"Plante","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101684_b0045","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early-stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101684_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2023.12.025","article-title":"Postsurgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies","volume":"182","author":"Recio","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.gore.2025.101684_b0055","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/ijgc-2024-005522","article-title":"Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer","volume":"34","author":"Rios-Doria","year":"2024","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"1","key":"10.1016\/j.gore.2025.101684_b0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3802\/jgo.2016.27.e1","article-title":"Isolated tumor cells and micro-metastases in regional lymph nodes in stage I to II endometrial cancer","volume":"27","author":"Todo","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101684_b0065","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.annonc.2024.08.2242","volume":"35","author":"Van Gorp","year":"2024","journal-title":"Ann. Oncol."},{"issue":"594","key":"10.1016\/j.gore.2025.101684_b0070","first-page":"e1","article-title":"Utilization of sentinel lymph node biopsy for uterine cancer","volume":"216","author":"Wright","year":"2017","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T01:39:45Z","timestamp":1739842785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":14,"alternative-id":["S2352578925000098"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101684","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence and survival in high-intermediate risk endometrial cancers with isolated tumor cell lymph node metastasis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101684"}}